These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33871224)

  • 1. Gut microbiota and non-alcoholic fatty liver disease.
    Abenavoli L; Procopio AC; Scarpellini E; Polimeni N; Aquila I; Larussa T; Boccuto L; Luzza F
    Minerva Gastroenterol (Torino); 2021 Dec; 67(4):339-347. PubMed ID: 33871224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
    Ezzaidi N; Zhang X; Coker OO; Yu J
    Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases.
    Sharma SP; Suk KT; Kim DJ
    World J Gastroenterol; 2021 Oct; 27(37):6161-6179. PubMed ID: 34712025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
    Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota mediated molecular events and therapy in liver diseases.
    Qi X; Yang M; Stenberg J; Dey R; Fogwe L; Alam MS; Kimchi ET; Staveley-O'Carroll KF; Li G
    World J Gastroenterol; 2020 Dec; 26(48):7603-7618. PubMed ID: 33505139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.
    Bakhshimoghaddam F; Alizadeh M
    Clin Nutr ESPEN; 2021 Aug; 44():61-68. PubMed ID: 34330514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function.
    Sharpton SR; Ajmera V; Loomba R
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):296-306. PubMed ID: 30196156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
    Jennison E; Byrne CD
    Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay.
    Abenavoli L; Giubilei L; Procopio AC; Spagnuolo R; Luzza F; Boccuto L; Scarpellini E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease.
    Yang YJ; Ni YH
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S55-S61. PubMed ID: 30509561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome.
    Abenavoli L; Scarlata GGM; Scarpellini E; Boccuto L; Spagnuolo R; Tilocca B; Roncada P; Luzza F
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review.
    Mohammadi Z; Poustchi H; Motamed-Gorji N; Eghtesad S; Hekmatdoost A; Saniee P; Merat S
    Arch Iran Med; 2020 Jan; 23(1):44-52. PubMed ID: 31910634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-liver crosstalk: A multihit therapeutic target for liver disease.
    Kirundi J; Moghadamrad S; Urbaniak C
    World J Gastroenterol; 2023 Mar; 29(11):1651-1668. PubMed ID: 37077519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease.
    Chi Y; Lin Y; Lu Y; Huang Q; Ye G; Dong S
    Sci Total Environ; 2019 Feb; 653():274-282. PubMed ID: 30412872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review.
    Chen YH; Wu WK; Wu MS
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
    Del Barrio M; Lavín L; Santos-Laso Á; Arias-Loste MT; Odriozola A; Rodriguez-Duque JC; Rivas C; Iruzubieta P; Crespo J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.